These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5954284)

  • 1. The effects of penicillamine therapy on uric acid metabolism in Wilson's disease.
    Sorensen LB; Kappas A
    Trans Assoc Am Physicians; 1966; 79():157-64. PubMed ID: 5954284
    [No Abstract]   [Full Text] [Related]  

  • 2. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
    Hauftová D; Slavícek J; Hartl J; Seidlová V; Komenda S
    Vnitr Lek; 1970 Apr; 16(4):344-53. PubMed ID: 5443326
    [No Abstract]   [Full Text] [Related]  

  • 3. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L; Campanella G; D'Addabbo A
    Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatolenticular degeneration, Wilson's disease. A characteristics case with remission under penicillamine therapy].
    Hansen J; Andersen OS
    Ugeskr Laeger; 1969 Jul; 131(31):1306-9. PubMed ID: 5824791
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of neurologic manifestations of Wilson's disease using penicillamine].
    Hartl J; Hauftová D
    Cesk Neurol; 1970 Mar; 33(2):89-93. PubMed ID: 5417217
    [No Abstract]   [Full Text] [Related]  

  • 8. The renal clearance of amino acids in a patient with Wilson's disease during penicillamine treatment.
    Bell GE; Slivka DC; Huston JR
    J Lab Clin Med; 1968 Jan; 71(1):113-21. PubMed ID: 5634999
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatocerebral degeneration (Wilson's disease). 2. Therapy].
    Werner T; Weinmann H
    Med Klin; 1965 Nov; 60(46):1856-9. PubMed ID: 5884683
    [No Abstract]   [Full Text] [Related]  

  • 10. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pregnancy and delivery in a woman with Wilson's disease (degeneratio hepatoleuticularis)].
    Pierzchała W; Zamłyński J; Rzempołuch J
    Pol Tyg Lek; 1994 Feb 21-28; 49(8-9):200-1. PubMed ID: 8084826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term D-penicillamine therapy of Wilson's disease in childhood. Changes in blood coagulation and effects on the haematopoetic system].
    Hayek HW; Schnack H; Widhalm S
    Wien Klin Wochenschr; 1973 Feb; 85(8):122-5. PubMed ID: 4632215
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic effects of penicillamine on Wilson's disease].
    Takagi H; Yoshida K; Okamura S; Maehashi M
    Nihon Rinsho; 1965 Oct; 23(10):2038-44. PubMed ID: 5895380
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recent findings in the therapy of Wilson's disease].
    Rigardetto R; Trevisio A
    Minerva Pediatr; 1975 Feb; 27(3):177-86. PubMed ID: 1226193
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution to the clarification of the pathogenesis of osteopathies in Wilson's disease. (Hepatolenticular degeneration)].
    Vokrouhlická-RösslerovI ; Vodicková L; Neruda O
    Vnitr Lek; 1967 Oct; 13(10):1018-22. PubMed ID: 5630545
    [No Abstract]   [Full Text] [Related]  

  • 16. [Wilson's disease treated with penicillamine (author's transl)].
    Aksamija-Rizvić B
    Lijec Vjesn; 1976 Aug; 98(8):430-1. PubMed ID: 1004094
    [No Abstract]   [Full Text] [Related]  

  • 17. [Wilson's disease treated by penicillamine: favorable effect].
    Petit H
    Lille Med; 1968 Dec; 13(10):1132-4. PubMed ID: 5711646
    [No Abstract]   [Full Text] [Related]  

  • 18. [Penicillamine in the treatment of Wilson's disease. Clinical picture].
    Hauftová D; Hartl J; Seidlová V; Růzicková R; Kubĕna K; Slavícek J
    Vnitr Lek; 1970 Apr; 16(4):337-43. PubMed ID: 5429582
    [No Abstract]   [Full Text] [Related]  

  • 19. [Penicillamine treatment of Wilson's disease].
    Falkmer S; Samuelson G; Sjölin S
    Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
    [No Abstract]   [Full Text] [Related]  

  • 20. [The topography of P300 in neuropsychiatric pharmacotherapy. III. Cognitive P300 fields in an organic psychosyndrome (Wilson's disease) before and during treatment with D-penicillamine].
    Maurer K; Ihl R; Dierks T
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1988 Jun; 19(2):62-4. PubMed ID: 3135996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.